TNK BIOTECH ApS: Financial statements 2019
CVR: 30691911
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
TNK BIOTECH ApS (CVR 30691911) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -13,209 and a net result of DKK -17,521 compared with DKK 3,168 the year before. Equity in the 2019 report amounted to DKK 8,322. The solvency ratio was 28.9%.
- Gross Profit
- DKK -13,209
- Profit/Loss
- DKK -17,521
- Equity
- DKK 8,322
- Total Assets
- DKK 28,758
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -13 t. | -18 t. | 8 t. | - |
| 2018 | - | 6 t. | 3 t. | 26 t. | - |
| 2017 | - | -10 t. | -14 t. | 23 t. | - |
| 2016 | - | -10 t. | -11 t. | 37 t. | - |
| 2015 | - | -32 t. | -41 t. | 48 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
TNK BIOTECH ApS has published its annual report for 2018. Gross profit came to DKK 6,070, and the net result was DKK 3,168.
About TNK BIOTECH ApS
TNK BIOTECH ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2007. The company is registered under the industry Investering for egen regning. The company was previously named TNK INVEST ApS. The management consists of Thomas Nitschke Kledal. The company is owned by Thomas Nitschke Kledal. The company has 0 employees (2013). In 2025, the company reported a gross profit of DKK -11,363 and a net result of DKK -17,528 compared with DKK -15,724 the year before. Equity in the 2025 report amounted to DKK -82,154.